title: PRODIACOR: a patient-centered treatment program for type 2 diabetes and associated cardiovascular risk factors in the city of Corrientes, Argentina: study design and baseline data.
abstract: OBJECTIVE
  To implement a controlled clinical trial (PRODIACOR) in a primary care setting designed 1) to improve type 2 diabetes care and 2) to collect cost data in order to be able to measure cost-effectiveness of three system interventions (checkbook of indicated procedures, patient/provider feedback and complete coverage of medications and supplies) and physician and/or patient education to improve psychological, clinical, metabolic and therapeutic indicators. All three Argentinean health subsectors (public health, social security and the private, prepaid system) are participants in the study. Patients of participating physicians were randomly selected and assigned to one of four groups: control, provider education, patient education, and provider/patient education; the system interventions were provided to all four groups.
  
  
  RESULTS
  Mean BMI was 29.8 kg/m(2); most subjects had blood pressure, fasting glucose and total cholesterol above targets recommended by international standards. Only 1% had had microalbuminuria measured, 57% performed glucose self-monitoring, 37% had had an eye examination and 31% a foot examination in the preceding year. Ten percent, 26% and 73% of people with hyperglycemia, hypertension and dyslipidemia, respectively, were not on medications. Most patients treated with either insulin or oral antidiabetic agents were on monotherapy as were those treated for hypertension and dyslipidemia. WHO-5 questionnaire scores indicated that 13% of the subjects needed psychological intervention.
  
  
  CONCLUSIONS
  Baseline data show multiple deficiencies in the process and outcomes of care that could be targeted and improved by PRODIACOR intervention.
authors.affiliation: CENEXA - Center of Experimental and Applied Endocrinology (UNLP-CONICET, National University of La Plata-National Research Council, PAHO/WHO Collaborating Center), Argentina. cenexa@speedy.com.ar
authors.forename: J J
authors.initials: JJ
authors.lastname: Gagliardino
authors.forename: S
authors.initials: S
authors.lastname: Lapertosa
authors.forename: M
authors.initials: M
authors.lastname: Villagra
authors.forename: J E
authors.initials: JE
authors.lastname: Caporale
authors.forename: P
authors.initials: P
authors.lastname: Oliver
authors.forename: C
authors.initials: C
authors.lastname: Gonzalez
authors.forename: F
authors.initials: F
authors.lastname: Siri
authors.forename: Ch
authors.initials: Ch
authors.lastname: Clark
mesh_terms: D000368:Aged; D001118:Argentina; D015992:Body Mass Index; D002318:Cardiovascular Diseases / Q000628:therapy*; D003625:Data Collection / Q000706:statistics & numerical data; D003924:Diabetes Mellitus, Type 2 / Q000628:therapy*; D005260:Female; D006305:Health Status Indicators; D006801:Humans; D007318:Inservice Training; D008297:Male; D008875:Middle Aged; D010353:Patient Education as Topic; D017060:Patient Satisfaction; D018802:Patient-Centered Care; D011320:Primary Health Care; D011785:Quality Assurance, Health Care; D016032:Randomized Controlled Trials as Topic / Q000379:methods* / Q000706:statistics & numerical data; D017010:Reminder Systems; D012107:Research Design; D012307:Risk Factors; D018401:Sample Size